90 related articles for article (PubMed ID: 26195717)
1. Biliary Tract Cancers: Finding Better Ways to Lump and Split.
Kelley RK; Bardeesy N
J Clin Oncol; 2015 Aug; 33(24):2588-90. PubMed ID: 26195717
[No Abstract] [Full Text] [Related]
2. BINGO: targeted therapy for advanced biliary-tract cancer.
Valle JW
Lancet Oncol; 2014 Jul; 15(8):778-80. PubMed ID: 24852117
[No Abstract] [Full Text] [Related]
3. SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
Ben-Josef E; Guthrie KA; El-Khoueiry AB; Corless CL; Zalupski MM; Lowy AM; Thomas CR; Alberts SR; Dawson LA; Micetich KC; Thomas MB; Siegel AB; Blanke CD
J Clin Oncol; 2015 Aug; 33(24):2617-22. PubMed ID: 25964250
[TBL] [Abstract][Full Text] [Related]
4. Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
Guan YS; Qing He ; Ping Li ; Fu YC; Zhao SW
Integr Cancer Ther; 2008 Mar; 7(1):51-3. PubMed ID: 18292595
[TBL] [Abstract][Full Text] [Related]
5. Time to move to targeted drugs in biliary tract cancer?
Louvet C; Tournigand C
Onkologie; 2010; 33(1-2):10-1. PubMed ID: 20164655
[No Abstract] [Full Text] [Related]
6. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma and the role of radiation and chemotherapy.
Price P
Hepatogastroenterology; 2001; 48(37):51-2. PubMed ID: 11268997
[TBL] [Abstract][Full Text] [Related]
8. [Radiotherapy for carcinomas of the biliary tract].
Tamamoto T; Asakawa I; Hasegawa M; Yoshimura H
Nihon Rinsho; 2006 Jan; 64 Suppl 1():513-7. PubMed ID: 16457316
[No Abstract] [Full Text] [Related]
9. The role of radiation therapy in cancer of the extra-hepatic biliary system: an analysis of thirteen patients and a review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy.
Kopelson G; Harisiadis L; Tretter P; Chang CH
Int J Radiat Oncol Biol Phys; 1977; 2(9-10):883-94. PubMed ID: 73534
[No Abstract] [Full Text] [Related]
10. Cholangiocarcinoma.
Squadroni M; Tondulli L; Gatta G; Mosconi S; Beretta G; Labianca R
Crit Rev Oncol Hematol; 2017 Aug; 116():11-31. PubMed ID: 28693792
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy in the treatment of subhepatic carcinomas.
Petera J; Kasaová L; Paluska P; Sirák I; Jansa J; Macingová Z; Dvorák J; Soumarova R
Hepatogastroenterology; 2011; 58(106):331-5. PubMed ID: 21661392
[TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate for palliative second-line treatment of advanced biliary tract cancer: a bicentric phase II study.
Roth A; Schleyer E; Schoppmeyer K; Kluge R; Wittekind C; Mössner J; Wiedmann M
Onkologie; 2011; 34(8-9):469-70. PubMed ID: 21934349
[No Abstract] [Full Text] [Related]
13. Adenocarcinomas of stomach, pancreas, liver, and biliary tracts. Survival of 328 patients treated with fluoropyrimidine therapy.
Davis HL; Ramirez G; Ansfield FJ
Cancer; 1974 Jan; 33(1):193-7. PubMed ID: 4272473
[No Abstract] [Full Text] [Related]
14. Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer.
Furuse J; Okusaka T; Funakoshi A; Yamao K; Nagase M; Ishii H; Nakachi K; Ueno H; Ikeda M; Morizane C; Horikawa Y; Mizuno N
Jpn J Clin Oncol; 2006 Sep; 36(9):552-6. PubMed ID: 16887837
[TBL] [Abstract][Full Text] [Related]
15. Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma.
Yashima Y; Sato S; Kawai T; Sugimoto T; Sato T; Kanda M; Obi S
Hepatol Int; 2015 Jan; 9(1):142-8. PubMed ID: 25788388
[TBL] [Abstract][Full Text] [Related]
16. [Multimodal treatment of cancer of the biliary tract].
Kawarada Y; Ogura Y; Mizumoto R
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):763-9. PubMed ID: 3389826
[TBL] [Abstract][Full Text] [Related]
17. Effects of the anti-epidermal growth factor receptor antibody cetuximab on cholangiocarcinoma of the liver.
Huang TW; Wang CH; Hsieh CB
Onkologie; 2007 Mar; 30(3):129-31. PubMed ID: 17341899
[TBL] [Abstract][Full Text] [Related]
18. [Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder].
Wiedmann M; Schoppmeyer K; Witzigmann H; Hauss J; Mössner J; Caca K
Z Gastroenterol; 2005 Mar; 43(3):305-15. PubMed ID: 15765304
[TBL] [Abstract][Full Text] [Related]
19. Gallbladder and extrahepatic bile duct carcinoma. Analysis of 1,808 cases.
Krain LS
Geriatrics; 1972 Nov; 27(11):111-7. PubMed ID: 5080807
[No Abstract] [Full Text] [Related]
20. [Systemic treatment of biliary tract cancer].
Jensen LH; Larsen O
Ugeskr Laeger; 2013 Oct; 175(42):2478-81. PubMed ID: 24629114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
